Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4530364
Max Phase: Preclinical
Molecular Formula: C19H22N4O3
Molecular Weight: 354.41
Molecule Type: Unknown
Associated Items:
ID: ALA4530364
Max Phase: Preclinical
Molecular Formula: C19H22N4O3
Molecular Weight: 354.41
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(NC(=O)c2cncc(N3CC4CC(C3)N4)c2)cc(OC)c1
Standard InChI: InChI=1S/C19H22N4O3/c1-25-17-5-13(6-18(7-17)26-2)22-19(24)12-3-16(9-20-8-12)23-10-14-4-15(11-23)21-14/h3,5-9,14-15,21H,4,10-11H2,1-2H3,(H,22,24)
Standard InChI Key: XSXAVZJQGIZHKP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 354.41 | Molecular Weight (Monoisotopic): 354.1692 | AlogP: 1.90 | #Rotatable Bonds: 5 |
Polar Surface Area: 75.72 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.12 | CX LogP: 1.11 | CX LogD: -0.60 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.85 | Np Likeness Score: -1.06 |
1. Murineddu G, Gotti C, Asproni B, Corona P, Martinello K, Plutino S, Fucile S, Temml V, Moretti M, Viani P, Schuster D, Piras S, Deligia F, Pinna GA.. (2019) Novel N-aryl nicotinamide derivatives: Taking stock on 3,6-diazabicyclo[3.1.1]heptanes as ligands for neuronal acetylcholine receptors., 180 [PMID:31299587] [10.1016/j.ejmech.2019.06.079] |
Source(1):